# Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.

Study · id `cardio:ct-nct07928505` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07928505](<https://clinicaltrials.gov/study/NCT07928505>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07928505

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07928505. Randomized; no masking; primary purpose prevention. Start 2027-01-15 (anticipated); primary completion 2029-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07928505, source copy `cardio:ctgov-nct07928505-2026-11-10`, retrieved 2026-11-18)
- Planned start: 2027-01-15 (anticipated) (ClinicalTrials.gov record NCT07928505, source copy `cardio:ctgov-nct07928505-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT07928505, source copy `cardio:ctgov-nct07928505-2026-11-10`, retrieved 2026-11-18)
- Completion: 2033-12-03 (anticipated) (ClinicalTrials.gov record NCT07928505, source copy `cardio:ctgov-nct07928505-2026-11-10`, retrieved 2026-11-18)
- Countries: Netherlands (ClinicalTrials.gov record NCT07928505, source copy `cardio:ctgov-nct07928505-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07928505-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.
- Acronym: SEAL-EVAR
- Condition: Endoleak After Endovascular Aneurysm Repair
- Condition: Aortic Aneurysm Abdominal
- Intervention (Device): AneuFix Injectable Polymer
- Intervention (Procedure): Endovascular AneuRysm Repair (EVAR)
- Lead sponsor: TripleMed B.V.
- Lead sponsor class: INDUSTRY
- Collaborator: Xper Research
- Collaborator class: INDUSTRY
- Collaborator: Clinfidence B.V.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as a collaborator: Xper Research (`cardio:org-xper-research`)

## Provenance

Content hash: fe5d4ffc1dbae18a578e9ce05daa300f19d9d15d7f7eec32c1e074c4d02dbbd8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
